European Haemophilia Consortium/X
Jul 23, 2025, 10:59
EHC Warns of Severe Impact from Von Willebrand Factor Supply Delays
The European Haemophilia Consortium (EHC) shared a post on X:
“Supply delays of Von Willebrand Factor can cause severe consequences for Von Willebrand Disease patients – worsening health, irreversible damage, hospitalisations, even death. Health systems must recognise Von Willebrand Factor as Critical Medicine.”
Stay informed with Hemostasis Today.
-
Apr 27, 2026, 23:24Leonardo Roever: The Emerging Role of the TyHGB Index in Predicting New-Onset Stroke
-
Apr 27, 2026, 20:25Shek Sady Khan: Addressing the Silent Burden of Venous Thromboembolism in Bangladesh
-
Apr 27, 2026, 16:04Heghine Khachatryan: Intracranial Hemorrhage in Leukemia – Beyond Thrombocytopenia
-
Apr 27, 2026, 15:56Marc Carrier: Supporting Thrombosis Canada in My Final Year as President
-
Apr 27, 2026, 15:52Tagreed Alkaltham։ You Think Eligibility Is About You… It’s Not
-
Apr 27, 2026, 15:52Emma Gasson: Top Abstract Oral Presentation at BSH 2026 on Cancer-Associated Thrombosis Microfluidics
-
Apr 27, 2026, 15:48Elliot Tapper: Continuing Anticoagulation Improves PVT Outcomes During Banding
-
Apr 27, 2026, 15:44Crisanto Torres: Early Plasma Administration Maximizes Survival in Traumatic Intracranial Hemorrhage
-
Apr 27, 2026, 15:38Key Insights from ESHMPN 26 on Advances in MPN Management – ESH